The Scientist

» infectious disease and disease/medicine

Most Recent

image: GM Mosquitoes Closer to Release in U.S.

GM Mosquitoes Closer to Release in U.S.

By | October 13, 2017

The EPA is now in charge of regulating the use of Oxitec’s strain of Aedes aegypti, genetically engineered to reduce populations of the insects.

2 Comments

A needle-free alternative to the finger-prick test would be a godsend for many sufferers of diabetes, but the industry has yet to clear the technological hurdles.

1 Comment

Spark Therapeutics’s Luxturna would be the first approved therapy in the U.S. that replaces or repairs a defective gene inherited from one’s parents.

1 Comment

Combined transcription and genome data from multiple tissues in hundreds of human donors reveal links between genotype and gene expression across the body.

1 Comment

image: Plague Ravaging Madagascar

Plague Ravaging Madagascar

By | October 10, 2017

Nearly four dozen people have died.

0 Comments

image: Zika Vaccine Shows Promise in Early Clinical Trial

Zika Vaccine Shows Promise in Early Clinical Trial

By | October 5, 2017

In humans, the DNA vaccine elicited the production of antibodies, which then protected mice from Zika infection.

0 Comments

Tissue recipients were treated as “guinea pigs,” says investigation leader.

0 Comments

Mice receiving the treatment produced their own monoclonal antibodies and survived infection with the life-threatening pathogen Pseudomonas aeruginosa.

2 Comments

image: Giants of Circadian Biology Win Nobel Prize

Giants of Circadian Biology Win Nobel Prize

By | October 2, 2017

The award in Physiology or Medicine goes to chronobiologists Jeffrey Hall, Michael Rosbash, and Michael Young.

1 Comment

image: Bathtub Bloodbath, 1793

Bathtub Bloodbath, 1793

By | October 1, 2017

French revolutionary Jean-Paul Marat took on many roles over the course of his life, including physician and scientist.

0 Comments

Popular Now

  1. GM Mosquitoes Closer to Release in U.S.
  2. Effects of Neanderthal DNA on Modern Humans
  3. Flux and Uncertainty in the CRISPR Patent Landscape
  4. Do Pathogens Gain Virulence as Hosts Become More Resistant?
RayBiotech